T. Hirata et al.
Bull. Chem. Soc. Jpn., 74, No. 3 (2001) 541
1′), 3.23 (1H, dd, J = 9.3, 7.8 Hz, H-2′), 3.31 (1H, m, H-3′), 3.37
(1H, t, J = 7.8 Hz, H-4′), 3.41 (1H, ddd, J = 7.8, 5.9, 2.0 Hz, H-5′),
3.73 (1H, dd, J = 11.7, 5.9 Hz, H-6a′), 4.03 (1H, dd, J = 11.7, 2.0
Hz, H-6b′), 4.31 (1H, d, J = 7.8 Hz, H-1′′), 3.16 (1H, dd, J = 8.3,
7.8 Hz, H-2′′), 3.30 (1H, m, H-3′′), 3.26 (1H, t, J = 8.8 Hz, H-4′′),
3.15 (1H, m, H-5′′), 3.63 (1H, dd, J = 11.7, 5.9 Hz, H-6a′′), 3.82
(1H, dd, J = 11.7, 2.4 Hz, H-6b′′); 13C NMR (CD3OD) see Table 3.
Incubation of (R)-1-Phenylethanol (1a) and (S)-1-Phenyl-
Table 3. 13C Chemical Shifts of the Products, 2a, 2b, 3
and 4, in the Biotransformation of 1-Phenylethanol (1)
by the Cultured Cells of C. roseus
Position
2a
2b
3
4
C-1
C-2
78.3
23.1
77.0
25.5
78.3
23.0
78.2
23.0
C-3
C-4
C-5
C-6
C-7
C-8
146.0
128.2
129.9
129.0
129.9
128.2
103.4
76.0
144.9
128.8
130.2
129.4
130.2
128.8
102.0
76.0
145.9
128.3
129.9
129.0
129.9
128.3
103.3
76.0
145.9
128.3
129.9
129.0
129.9
128.3
103.2
76.0
ethanol (1b) with the Cultured Cells of C. roseus.
According
to the same procedure as described above, 1a and 1b were trans-
formed into the corresponding glucosides. Samples of 1a and 1b
(60 mg) in MeOH (0.6 cm3) were administered to flask containing
the suspended cells (150 g), and the cultures were incubated at 25
°C for 5 days on a rotary shaker (75 rpm). The products were ex-
tracted and purified in the same way as for the biotransformation of
1. Purification of the products with preparative TLC and HPLC
gave the glycosides, 2a (3 mg), 3 (4 mg), 4 (2 mg) and 5a (14 mg)
from 1a, while the glycosides, 2b (2 mg) and 5b (5 mg) from 1b.
C-1ꢀ
C-2ꢀ
C-3ꢀ
C-4ꢀ
C-5ꢀꢀ
C-6ꢀꢀ
C-1ꢀꢀ
C-2ꢀꢀ
C-3
78.8a)
72.5
78.6b)
72.5
78.9c)
72.3
78.7d)
72.4
78.0a)
70.0
105.8
73.2
74.9
70.3
77.6b)
70.3
106.0
73.2
75.1
70.3
78.0c)
70.4
78.1d)
70.5
1-O-[α-
L
-arabinopyranosyl-(1-6)-β-D-glucopyranosyl]-(R)-1-
phenylethanol (2a): FABMS m/z 439 [M+Na]+; 1H NMR
(CD3OD) δ 4.96 (1H, q, J = 6.4 Hz, H-1), 1.48 (3H, d, J = 6.4 Hz,
H-2), 7.41 (2H, d, J = 7.3 Hz, H-4,8), 7.30 (2H, t, J = 7.3 Hz, H-
5,7), 7.21 (1H, t, J = 7.3 Hz, H-6), 4.46 (1H, d, J = 7.3 Hz, H-1′),
3.23 (1H, dd, J = 7.3, 8.7 Hz, H-2′), 3.32 (1H, m, H-3′), 3.27 (1H,
m, H-4′), 3.36 (1H, m, H-5′), 3.67 (1H, dd, J = 11.6, 6.7 Hz, H-6a′),
3.97 (1H, dd, J = 11.6, 2.1 Hz, H-6b′), 4.24 (1H, d, J = 7.0 Hz, H-
1′′), 3.53 (1H, dd, J = 8.8, 6.7 Hz, H-2′′), 3.41 (1H, dd, J = 8.8, 3.4
Hz, H-3′′), 3.73 (1H, m, H-4′′), 3.30 (1H, m, H-5a′′), 3.77 (1H, dd,
J = 12.5, 3.4 Hz, H-5b′′); 13C NMR (CD3OD) see Table 3.
106.2
75.7
105.6
76.0
78.3c)
72.0
78.9d)
72.4
C-4ꢀꢀ
C-5ꢀꢀ
C-6ꢀꢀ
67.4
—
67.5
—
67.6
—
78.7d)
63.5
a)–d) Assignments may be interchanged.
(RS)-1-phenylethanol (1) (20 mg) in MeOH (0.35 cm3) and glu-
cose (1.3 g) were administered to the cultured suspension cells (50
g), and the cultures were incubated at 25 °C for 10 days on a rotary
shaker (75 rpm). After incubation, the cells and medium were sep-
arated by filtration with suction. The cells were extracted with
MeOH and the extract was concentrated by evaporation in vacuo.
After the methanolic fraction was partitioned between H2O and
EtOAc, the aqueous layer was further extracted with BuOH. The
filtered medium was extracted with BuOH. The BuOH extracts
from the cells and the culture medium were combined and purified
by preparative TLC with MeOH:EtOAc (1:3) and HPLC with a
Puresil C18 column using MeOH:H2O (1:3 v/v) to give viciano-
side 2, primeveroside 3, gentiobioside 4, and 1-phenylethyl β-D-
glucopyranoside 5.12 The structures of the products were deter-
mined by means of FABMS, 1H and 13C NMR, H–H COSY, C–H
COSY, and HMBC measurements. The diastereomeric excess of 2
was determined by the intensities of the anomeric proton signals of
the arabinose moiety in its 1H NMR spectra.
1-O-[α-
L
-arabinopyranosyl-(1-6)-β-D-glucopyranosyl]-(S)-1-
phenylethanol (2b): FABMS m/z 439 [M+Na]+; 1H NMR
(CD3OD) δ 5.01 (1H, q, J = 7.3 Hz, H-1), 1.45 (3H, d, J = 7.3 Hz,
H-2), 7.42 (2H, d, J = 7.3 Hz, H-4,8), 7.31 (2H, t, J = 7.3 Hz, H-
5,7), 7.24 (1H, t, J = 7.3 Hz, H-6), 4.06 (1H, d, J = 7.3 Hz, H-1′),
3.23 (1H, dd, J = 7.3,8.5 Hz, H-2′), 3.20 (1H, t, J = 8.5 Hz, H-3′),
3.32 (1H, dd, J = 8.5, 10.1 Hz, H-4′), 3.28 (1H, m, H-5′), 3.73 (1H,
dd, J = 11.0, 6.1 Hz, H-6a′), 4.06 (1H, dd, J = 11.0, 1.8 Hz, H-6b′),
4.34 (1H, d, J = 6.4 Hz, H-1′′), 3.62 (1H, dd, J = 8.2, 6.4 Hz, H-2′′),
3.55 (1H, dd, J = 8.2, 1.8 Hz, H-3′′), 3.81 (1H, m, H-4′′), 3.55 (1H,
dd, J = 12.2, 1.8 Hz, H-5a′′), 3.87 (1H, dd, J = 12.2, 2.4 Hz, H-
5b′′); 13C NMR (CD3OD) see Table 3.
Determination ofAbsolute Configuration of Sugar Moieties.
Each of the disaccharides, 2a, 2b, 3, and 4, was added to the vial in
4.0 M HCl (100 mm3) and heated to 80 °C for 2 h and then cooled.
After removing of the solvent in a stream of N2, each hydrolysate
was converted into a pentafluoropropionate with pentafluoropropi-
onic anhydride (400 mm3) in CH2Cl2 (400 µL) in a sealed tube at
120 °C for 2 h. Excess reagents were removed under a stream of N2
and the derivatives were analyzed by chiral GC on Chirasil-Val.
The peaks of the derivatives from vicianosides 2 and 2b were as-
signed to those of L-arabinose and D-glucose, peaks of the deriva-
tives from primeveroside 3 to those of D-xylose and D-glucose, and
peaks of the derivatives from gentiobioside 4 to that of D-glucose.
Time Course Experiments in the Glycosylation of (RS)-1-
Phenylethanol (1). Each 50 g of the suspension cells of C. roseus
was portioned to 5 flasks containing 100 ml of the SH medium.
(RS)-1-Phenylethanol (1) (21 mg) and glucose (1.3 g) were admin-
istered to the flasks and the mixtures were incubated on a rotary
shaker (75 rpm) at 25 °C. At a regular time interval, the cells and
medium were separated by filtration. The cells were extracted with
MeOH and the extract was concentrated by evaporation in vacuo.
The methanolic fraction was combined with the medium and the
1-O-[β-
D
-xylopyranosyl-(1-6)-β-D-glucopyranosyl]-(R)-1-
phenylethanol (3) (primeveroside): FABMS m/z 439 [M+Na]+;
1H NMR (CD3OD) δ 4.96 (1H, q, J = 6.4 Hz, H-1), 1.45 (3H, d, J =
6.4 Hz, H-2), 7.41 (2H, d, J = 7.3 Hz, H-4,8), 7.30 (2H, t, J = 7.3
Hz, H-5,7), 7.21 (1H, t, J = 7.3 Hz, H-6), 4.46 (1H, d, J = 8.3 Hz, H-
1′), 3.25 (1H, m, H-2′), 3.38 (1H, m, H-3′), 3.32 (1H, m, H-4′),
3.40 (1H, m, H-5′), 3.67 (1H, dd, J = 11.6, 5.8 Hz, H-6a′), 3.97 (1H,
dd, J = 11.6, 1.8 Hz, H-6b′), 4.26 (1H, d, J = 7.3 Hz, H-1′′), 3.16
(1H, dd, J = 8.8, 7.6 Hz, H-2′′), 3.28 (1H, m, H-3′′), 3.44 (1H, m,
H-4′′), 3.08 (1H, dd, J = 11.6, 10.1 Hz, H-5a′′), 3.79 (1H, dd, J =
11.6, 3.4 Hz, H-5b′′); 13C NMR (CD3OD) see Table 3.
1-O-[β-
D
-glucopyranosyl-(1-6)-β-D-glucopyranosyl]-(R)-1-
phenylethano
l
(4) (gentiobioside): FABMS m/z 447 [M+H]+;
1H NMR (CD3OD) δ 4.97 (1H, q, J = 6.4 Hz, H-1), 1.47 (3H, d, J =
6.4 Hz, H-2), 7.42 (2H, d, J = 7.3 Hz, H-4,8), 7.30 (2H, t, J = 7.3
Hz, H-5,7), 7.22 (1H, t, J = 7.3 Hz, H-6), 4.47 (1H, d, J = 7.8 Hz, H-